$5.360
+1.245 (+23.22%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
PRME-Prognose durch Analyse ähnlicher Charts
Alphio's PRME stock price prediction model matches the current Prime Medicine, Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.30 (-1.21%). The 1-week path is $5.46 (+1.87%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Prime Medicine, Inc-Aktien kaufen?
Prime Medicine Inc is a good buy right now at a current price of $3.67, especially considering the positive analyst ratings and recent arbitration victory that boosted market confidence. The stock has a 5-day change of +5.76% and a 20-day change of +26.55%, indicating strong short-term momentum. However, the main risk is the company's ongoing net losses, with a net income of -42,109,000 USD in Q2 2026, which investors should monitor closely.
PRME schloss am Wednesday bei $5.36, nachdem der Kurs +23.22% gestiegen ist
Prime Medicine, Inc (PRME) last closed at $5.3600001, gaining +23.22%. These facts feed the 1-day and 1-week PRME price prediction above.
Prognose-Treiber
Die Prognose-Treiber von Prime Medicine, Inc (PRME) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf PRME am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für PRME
Historically the probability of a positive October return for PRME is 54.55%. October offers the highest probability of a positive month at 54.55%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.